InMode ended 2025 with $555.3 million in cash, cash equivalents, marketable securities and deposits, underscoring a strong balance sheet. The company returned $127.4 million to shareholders through ...

InMode (NASDAQ:INMD) executives said the company’s fourth quarter results came in “slightly better than expected” as the broader aesthetic market continued to face pressure from higher interest rates ...

IRVINE, Calif., May 6, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, reports that the US District Court for the Central District of ...

Thank you, Miri, and to everyone for joining us. With me today are Dr. Michael Crindel, our Co-Founder and Chief Technology Officer, Yair Malca, our Chief Financial Officer, and Rafael Liqueman, our ...

Good day, and welcome to InMode's second quarter 2024 earnings results conference call. All participants will be in listen-only mode. [Operator instructions]. After today's presentation, there will be ...

You & I Primary Care, Aesthetics and Wellness believes that beauty doesn’t have to equal pain. A pioneer in non-surgical aesthetic medicine, the medical practice is pleased as it announces its ...

LAKE FOREST, Calif., Aug. 13, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to announce a new FDA clearance to ...

InMode Ltd. ( INMD) Q4 2025 Earnings Call February 10, 2026 8:30 AM EST ...

Good day, and welcome to the InMode fourth quarter and full year 2024 earnings results conference call. [Operator instructions] Please note, this event is being recorded. I would now like to turn the ...